This company listing is no longer active
This company may still be operating, however this listing is no longer active. Find out why through their latest events.
このページの翻訳は実験的なもので、現在 開発中です。お待ちしております！
RDUS 株式概要
Radius Health, Inc., a biopharmaceutical company, focuses on addressing unmet medical needs in the areas of bone health, orphan diseases, and oncology.
Radius Health, Inc. 競合他社
価格と性能
| 過去の株価 | |
|---|---|
| 現在の株価 | US$10.10 |
| 52週高値 | US$23.00 |
| 52週安値 | US$4.97 |
| ベータ | 0.52 |
| 11ヶ月の変化 | -0.39% |
| 3ヶ月変化 | 78.76% |
| 1年変化 | -27.08% |
| 33年間の変化 | -55.21% |
| 5年間の変化 | -71.49% |
| IPOからの変化 | 26.09% |
最新ニュース
Radius Recycling: An Attractive, But Volatile, Play On A Cleaner Future
Jun 03Radius stock rises as elacestrant gets FDA priority review to treat breast cancer subtype
Aug 11Recent updates
Radius Recycling: An Attractive, But Volatile, Play On A Cleaner Future
Jun 03Radius stock rises as elacestrant gets FDA priority review to treat breast cancer subtype
Aug 11Reevaluating Radius Health
Feb 24Radius Health EPS misses by $0.02, misses on revenue
May 07When Will Radius Health, Inc. (NASDAQ:RDUS) Become Profitable?
Feb 23
Revisiting Radius Health
Feb 01Radius Health acquires global rights to RAD011 in Prader-Willi syndrome
Jan 06How Much Did Radius Health's(NASDAQ:RDUS) Shareholders Earn From Share Price Movements Over The Last Five Years?
Jan 01
Radius Health on-track for record quarterly revenue for TYMLOS-SC
Dec 15株主還元
| RDUS | US Biotechs | US 市場 | |
|---|---|---|---|
| 7D | -0.1% | -0.3% | 0.3% |
| 1Y | -27.1% | 11.0% | 22.5% |
業界別リターン: RDUS underperformed the US Biotechs industry which returned -22.1% over the past year.
リターン対市場: RDUS underperformed the US Market which returned -11.6% over the past year.
価格変動
| RDUS volatility | |
|---|---|
| RDUS Average Weekly Movement | 9.8% |
| Biotechs Industry Average Movement | 10.3% |
| Market Average Movement | 5.7% |
| 10% most volatile stocks in US Market | 15.3% |
| 10% least volatile stocks in US Market | 2.8% |
安定した株価: RDUS's share price has been volatile over the past 3 months.
時間の経過による変動: RDUS's weekly volatility (10%) has been stable over the past year.
会社概要
| 設立 | 従業員 | CEO（最高経営責任者 | ウェブサイト |
|---|---|---|---|
| 2003 | 293 | G. Martin | radiuspharm.com |
Radius Health, Inc. 基礎のまとめ
| RDUS 基礎統計学 | |
|---|---|
| 時価総額 | US$480.77m |
| 収益（TTM） | -US$68.63m |
| 売上高(TTM) | US$223.36m |
2.2x
P/Sレシオ-7.0x
PER（株価収益率RDUS は割高か？
公正価値と評価分析を参照収益 と収入
| RDUS 損益計算書（TTM） | |
|---|---|
| 収益 | US$223.36m |
| 売上原価 | US$19.47m |
| 売上総利益 | US$203.89m |
| その他の費用 | US$272.52m |
| 収益 | -US$68.63m |
直近の収益報告
Jun 30, 2022
次回決算日
該当なし
| 一株当たり利益（EPS） | -1.44 |
| グロス・マージン | 91.28% |
| 純利益率 | -30.72% |
| 有利子負債／自己資本比率 | -124.2% |
RDUS の長期的なパフォーマンスは？
過去の実績と比較を見る